Pr Ghassan Abou-Alfa

SAB Member

Dr. Ghassan Abou-Alfa is an attending physician part of the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center in New York. Dr. Abou-Alfa specializes in the treatment of gastrointestinal cancers and in particular, liver and biliary cancers.
He serves as the chair the medical/scientific board of the Cholangiocarcinoma Foundation and the Blue Faery Liver Foundation, and also serves on the National Medical Advisory Committee of the American Liver Foundation.

Pr Ahmad Awada

SAB Member

Dr. Awada is Head of Medicine Department and Medical Oncology, at Jules Bordet Cancer Institute Brussels, Université Libre de Bruxelles Belgium. He is membership of several international scientific societies (ASCO, EORTC, ESMO), co-founder of Oncodistinct network for oncology reserarch and Professor of Clinical Medicine at the Université Libre de Bruxelles. Dr Awada took an active part in the development of new drugs, some of them already widely used. He is author or co-author of 28 book chapters and, 329 articles in international publications.

Pr Eric Raymond

SAB Member

Dr. Raymond is Chair of Medical Oncology at Paris Saint-Joseph Hospital Group. He is also our Chief Medical Officer and Principal Investigator of >50 clinical trials, including phase I, II, and III studies. Researches have been focused on molecular pharmacology, translational research, and early phase clinical trials (phase I and early phase II). Medical activities have focused on budget compliences, administration and management, quality and optimization of out- and in-patient cares as well as treatment innovations.

Dr Raphaël Rodriguez

SAB Member

Dr. Rodriguez is Director of Research at Institut Curie. He has developed original small molecules and protocols to dissect cellular processes relevant to human health including aging and cancer. He is primarily interested in the chemistry of cancer. He is the co-author/inventor of 65 articles, book chapters and patents and commercialized several biologically active small molecules. After several awards, he has been recently elected Fellow of the Royal Society of Chemistry and Franco-British Young Leaders.

Pr Juan Valle

SAB Member

Dr. Valle is Professor and Honorary Consultant in Medical Oncology at The Christie NHS Foundation Trust. He is specialized in Cancers of the pancreas, biliary tract (cholangiocarcinoma and gallbladder cancer), liver and neuroendocrine tumours. Major achievements include international recognition for research in the field of biliary tract cancers, particularly through establishing the reference treatment for patients with advanced disease `{`ABC-02 study, published in the prestigious New Engl J Med in 2010`}`.